ğŸ§¬ GENE OF THE WEEK: ACE

The blood pressure gene with athletic implications. ACE I/D polymorphism predicts endurance vs power performance and cardiovascular drug response.

ACE (Angiotensin-Converting Enzyme) regulates blood pressure through the renin-angiotensin system. The I/D polymorphism has dual relevance:

II Genotype (Insertion):

ğŸƒ Lower ACE activity
ğŸƒ Better endurance performance
ğŸƒ Efficient oxygen utilization
ğŸƒ Elite marathon runners overrepresented
ğŸƒ Mountaineers, rowers
ğŸƒ Lower blood pressure baseline

DD Genotype (Deletion):

ğŸ’ª Higher ACE activity
ğŸ’ª Better power/strength performance
ğŸ’ª Sprint performance advantage
ğŸ’ª Greater muscle hypertrophy potential
ğŸ’ª Higher blood pressure risk
ğŸ’ª May benefit most from ACE inhibitors

Pharmacogenomic Relevance:

ACE inhibitors (lisinopril, enalapril, ramipril) are first-line hypertension drugs. DD genotype individuals often have:
â†’ The highest baseline ACE activity
â†’ The most benefit from ACE inhibitors
â†’ Better blood pressure response

Know your genotype to optimize both athletic training and medication selection.

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#GeneOfTheWeek #ACE #BloodPressure #Athletics #Pharmacogenomics #Bioscope
